Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,114 | 72 | 98.6% |
| Education | $15.42 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $282.21 | 20 | $0 (2020) |
| PFIZER INC. | $125.96 | 9 | $0 (2024) |
| Novo Nordisk Inc | $103.06 | 6 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.68 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $60.78 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $57.51 | 3 | $0 (2018) |
| SANOFI PASTEUR INC. | $57.08 | 3 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $53.57 | 3 | $0 (2021) |
| Lilly USA, LLC | $49.81 | 3 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $48.27 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.28 | 1 | PFIZER INC. ($24.28) |
| 2022 | $15.35 | 1 | Lilly USA, LLC ($15.35) |
| 2021 | $120.31 | 7 | Novo Nordisk Inc ($41.22) |
| 2020 | $102.42 | 6 | GlaxoSmithKline, LLC. ($45.64) |
| 2019 | $111.14 | 8 | Vanda Pharmaceuticals Inc. ($18.17) |
| 2018 | $372.25 | 24 | GlaxoSmithKline, LLC. ($116.12) |
| 2017 | $383.76 | 27 | GlaxoSmithKline, LLC. ($120.45) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: DERMATOLOGY | ||||||
| 06/29/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 10/15/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Obesity | ||||||
| 09/30/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: VACCINE | ||||||
| 09/24/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardio-renal | ||||||
| 08/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: PRIMARY CARE | ||||||
| 05/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Diabetes | ||||||
| 05/19/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/13/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: VACCINES | ||||||
| 03/11/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VACCINES | ||||||
| 02/25/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Endocrinology | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiovascular | ||||||
| 02/04/2020 | SANOFI PASTEUR INC. | ADACEL (Biological), MENACTRA, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Vaccines | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/18/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), ADACEL, FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
| 06/11/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/14/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: VACCINE | ||||||
| 03/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: VACCINES | ||||||
| 01/15/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 12/19/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 540 | 626 | $87,270 | $26,639 |
| 2022 | 8 | 483 | 536 | $75,038 | $22,572 |
| 2021 | 8 | 526 | 572 | $78,495 | $34,283 |
| 2020 | 8 | 479 | 534 | $78,440 | $30,546 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 229 | 229 | $32,060 | $9,000 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 152 | $27,360 | $7,265 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 101 | $12,322 | $5,419 | 44.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $8,184 | $1,899 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,780 | $1,636 | 43.3% |
| 77081 | Dxa bone density measurement of forearm, finger, hand, or foot | Office | 2023 | 16 | 16 | $1,040 | $517.92 | 49.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 14 | $560.00 | $439.18 | 78.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 24 | $1,200 | $244.13 | 20.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 25 | $764.00 | $218.69 | 28.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 186 | 186 | $26,040 | $7,248 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 117 | $14,274 | $5,739 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 113 | $20,340 | $5,254 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 49 | 49 | $9,114 | $2,226 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,420 | $1,318 | 38.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $800.00 | $614.37 | 76.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 21 | $1,050 | $175.02 | 16.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 256 | 256 | $35,840 | $10,332 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 112 | $20,160 | $10,287 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $9,114 | $6,759 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 75 | 79 | $9,638 | $5,480 | 56.9% |
| 77081 | Bone density measurement of the core or extremities (e.g., radius, wrist, heel) | Office | 2021 | 17 | 17 | $1,105 | $567.97 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 24 | $960.00 | $425.32 | 44.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 21 | 23 | $1,150 | $260.82 | 22.7% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 12 | 12 | $528.00 | $170.16 | 32.2% |
About Dr. Leslie Mohlman, MD
Dr. Leslie Mohlman, MD is a Internal Medicine healthcare provider based in Bristol, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265433262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leslie Mohlman, MD has received a total of $1,130 in payments from pharmaceutical and medical device companies, with $24.28 received in 2024. These payments were reported across 74 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,114).
As a Medicare-enrolled provider, Mohlman has provided services to 2,028 Medicare beneficiaries, totaling 2,268 services with total Medicare billing of $114,040. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Bristol, RI
- Active Since 08/02/2005
- Last Updated 04/18/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265433262
Products in Payments
- Victoza (Drug) $61.84
- TRELEGY ELLIPTA (Drug) $61.33
- SHINGRIX (Biological) $60.90
- Hetlioz (Drug) $48.27
- ANORO (Drug) $46.95
- BREO (Drug) $43.88
- Myrbetriq (Drug) $41.27
- BEXSERO (Biological) $39.53
- CHANTIX (Drug) $39.43
- FARXIGA (Drug) $38.89
- PREVNAR - 13 (Biological) $38.31
- STIOLTO (Drug) $37.32
- EUCRISA (Drug) $35.78
- TRULICITY (Drug) $34.46
- PNEUMOVAX 23 (Biological) $33.66
- ENTRESTO (Drug) $30.30
- Vascepa (Drug) $30.21
- NO PRODUCT DISCUSSED (Drug) $29.61
- Ozempic (Drug) $23.03
- TOUJEO (Drug) $20.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bristol
Dr. Bernard Grunstra, Md, MD
Internal Medicine — Payments: $36,895
Charles Villoch, Md, MD
Internal Medicine — Payments: $25,124
Dr. Joseph Foley, M.d, M.D
Internal Medicine — Payments: $21,160
Dr. Nathan Gargus, M.d, M.D
Internal Medicine — Payments: $17,677
Rick Whiles, Md, MD
Internal Medicine — Payments: $17,415
Dr. Donald Quinn, Md, MD
Internal Medicine — Payments: $17,216